The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

Abstract:

:To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome (pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of clinical involvements (glandular/extraglandular involvement), to the lack of correlation between symptoms of dryness and glandular function assessed by objective measurements, as well as between symptoms and systemic complications of the disease. Severe organ manifestations are generally treated by off-label therapies in accordance with current practice and guidelines for Systemic Lupus Erythematosus or other connective-tissue diseases. Despite a much greater understanding of the pathogenesis of pSS, modern drug development has resulted in no approval of therapy so far. In this study, we performed a systematic review of all targeted therapies under clinical development in pSS, in 17 main online registries of clinical trials. Our search identified 264 trials, from which 25 targeted therapies for pSS were included. The molecules under current clinical development for pSS target B cells (n = 4), T cells or T/B cells costimulation (n = 5), inflammatory cytokines or chemokines and their receptors (n = 5), intracellular signalling pathways (n = 7) and various other targets identified in pSS (n = 4). The current drug development pipeline in pSS may lead to valuable strategies for the treatment of this currently difficult-to-treat disease.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Felten R,Scher F,Sibilia J,Gottenberg JE,Arnaud L

doi

10.1016/j.autrev.2018.12.008

subject

Has Abstract

pub_date

2019-06-01 00:00:00

pages

576-582

issue

6

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(19)30086-2

journal_volume

18

pub_type

杂志文章
  • Juvenile idiopathic arthritis.

    abstract::One of the most enigmatic problems in rheumatology has been juvenile idiopathic arthritis (JIA). Firstly, the classification has often depended on clinical features that have variations between patients. Secondly, there are different classification schemes in usage and there are few objective serologic tests that help...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.09.011

    authors: Borchers AT,Selmi C,Cheema G,Keen CL,Shoenfeld Y,Gershwin ME

    更新日期:2006-04-01 00:00:00

  • The fresco of autoinflammatory diseases from the pediatric perspective.

    abstract::Autoinflammatory diseases are genetic or acquired clinical entities globally caused by the aberrant release of the proinflammatory cytokine interleukin-1 and mostly characterized by recurrent spontaneous inflammatory events which do not produce antigen-specific T cells or autoantibodies. Within the past decade, the li...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.10.008

    authors: Rigante D

    更新日期:2012-03-01 00:00:00

  • Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.

    abstract:OBJECTIVE:Low dose (10-25 mg/week) methotrexate is widely used for the management of systemic inflammatory diseases, and is considered to be relatively safe. Toxicity due to low dose MTX has been reported but is poorly characterized. We describe the clinical features, risk factors, and outcomes of low dose MTX toxicity...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.08.027

    authors: Kivity S,Zafrir Y,Loebstein R,Pauzner R,Mouallem M,Mayan H

    更新日期:2014-11-01 00:00:00

  • Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

    abstract::While the relationship between maternal connective tissue diseases and neonatal rashes was described in the 1960s and congenital heart block in the 1970s, the "culprit" antibody reactivity to the SSA/Ro-SSB/La ribonucleoprotein complex was not identified until the 1980s. However, studies have shown that approximately ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.07.013

    authors: Izmirly PM,Halushka MK,Rosenberg AZ,Whelton S,Rais-Bahrami K,Nath DS,Parton H,Clancy RM,Rasmussen S,Saxena A,Buyon JP

    更新日期:2017-09-01 00:00:00

  • Environmental factors and the geoepidemiology of juvenile idiopathic arthritis.

    abstract::Juvenile idiopathic arthritis (JIA), the most common chronic rheumatic disease of childhood, is a clinically heterogeneous group of disorders characterized by chronic inflammatory arthritis. JIA is considered to be an autoimmune disease, which is a result of immune reaction caused or triggered by environmental factors...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.018

    authors: Berkun Y,Padeh S

    更新日期:2010-03-01 00:00:00

  • Rituximab treatment for IgA vasculitis: A systematic review.

    abstract:BACKGROUND:Immunoglobulin A vasculitis (IgAV) is a systemic small vessel vasculitis for which treatment of severe cases is usually based on glucocorticoids and other conventional immunosuppressive drugs. The role of rituximab for resistant or refractory cases has been explored in isolated case reports and small series....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102490

    authors: Hernández-Rodríguez J,Carbonell C,Mirón-Canelo JA,Diez-Ruiz S,Marcos M,Chamorro AJ

    更新日期:2020-04-01 00:00:00

  • Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

    abstract::Dendritic cells (DCs) constitute a heterogeneous population of professional antigen presenting cells which are the initiators and key regulators for both immunity and tolerance induction. The significance and impact of DC biology in contemporary immunology and medical research is heightened by the award of the 2011 No...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.03.004

    authors: Chan VS,Nie YJ,Shen N,Yan S,Mok MY,Lau CS

    更新日期:2012-10-01 00:00:00

  • Novel image processing techniques to better understand white matter disruption in multiple sclerosis.

    abstract::In Multiple Sclerosis (MS) patients, conventional magnetic resonance imaging (MRI) shows a pattern of white matter (WM) disruption but may also overlook some WM damage. Diffusion tensor MRI (DT-MRI) can provide important in-vivo information about fiber direction that is not provided by conventional MRI. The geometry o...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.06.003

    authors: Goldberg-Zimring D,Warfield SK

    更新日期:2006-10-01 00:00:00

  • Rhupus: a systematic literature review.

    abstract::"Rhupus" or "rhupus syndrome" is a poorly described and underdiagnosed disease in which features of both rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) appear in the same patient, most often sequentially. The SLE-related involvement is usually mild, dominated by hematological abnormalities and skin, ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102612

    authors: Antonini L,Le Mauff B,Marcelli C,Aouba A,de Boysson H

    更新日期:2020-09-01 00:00:00

  • Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

    abstract::Rituximab is a monoclonal antibody directed against the CD20 antigen expressed on B cells and widely used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. There is a growing amount of literature which suggests that rituximab may be useful for inflammatory ocular diseases and intraocular lymphoma. F...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.07.001

    authors: Miserocchi E,Pontikaki I,Modorati G,Gattinara M,Meroni PL,Gerloni V

    更新日期:2011-11-01 00:00:00

  • Complex regional pain syndrome - False hopes and miscommunications.

    abstract::Complex regional pain syndrome (CRPS) has been considered to be an autoimmune disease and there have been clinical trials with intravenous immunoglobulin. Often the etiology of the so-called CRPS diagnosis cannot be discerned and there are no validated instruments that provide functional metrics. The term complex regi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.10.003

    authors: Chang C,McDonnell P,Gershwin ME

    更新日期:2019-03-01 00:00:00

  • Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls.

    abstract:OBJECTIVE:This case control study assessed: 1) the relationship of systemic sclerosis (SSc) related to exposure to heavy metals; and 2) the risk of SSc related to occupational exposure in male and female patients. METHODS:From 2005 to 2008, 100 patients with a definite diagnosis of SSc were included in the study; 3 ag...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.01.004

    authors: Marie I,Gehanno JF,Bubenheim M,Duval-Modeste AB,Joly P,Dominique S,Bravard P,Noël D,Cailleux AF,Benichou J,Levesque H,Goullé JP

    更新日期:2017-03-01 00:00:00

  • Epidemiological and ethical aspects of multiplex autoantibody testing.

    abstract::Arrays are one of the technologies able to detect autoantibodies by measuring simultaneously many thousands of markers from a unique biological sample. The main purpose of a diagnostic test is making an early and accurate diagnosis. From a statistical point of view, multiple testing increases the probability of false ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.01.008

    authors: Bidoli E,Villalta D,Ethical Committee of Pordenone Hospital, Italy.,Battistin M,Bidoli E,Cammarota A,Ciccone M,Fedato R,Lodi B,Marchesini F,Molaro G,Ostardo E,Rellini G,Sartori R,Schinella D

    更新日期:2007-06-01 00:00:00

  • Modulation of autoimmunity with artificial peptides.

    abstract::The loss of immune tolerance to self antigens leads to the development of autoimmune responses. Since self antigens are often multiple and/or their sequences may be known, one approach to restore immune tolerance uses synthetic artificial peptides that interfere or compete with self peptides in the networks of cellula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.017

    authors: La Cava A

    更新日期:2010-11-01 00:00:00

  • Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis.

    abstract:BACKGROUND:Anticardiolipin antibodies of the immunoglobulin G isotype (IgG aCL) have been suggested as risk factor for arterial and venous thrombosis. No conclusive data in patients with coronary artery disease (CAD) do exist. We investigate the risk of recurrent CAD according to the presence of IgG aCL. METHODS:We pe...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2019.03.005

    authors: Pastori D,Bucci T,Triggiani M,Ames PRJ,Parrotto S,Violi F,Pignatelli P,Farcomeni A

    更新日期:2019-05-01 00:00:00

  • Rett syndrome: An autoimmune disease?

    abstract::Rett syndrome (RTT) is a devastating neurodevelopmental disease, previously included into the autistic spectrum disorders, affecting almost exclusively females (frequency 1:10,000). RTT leads to intellective deficit, purposeful hands use loss and late major motor impairment besides featuring breathing disorders, epile...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.01.011

    authors: De Felice C,Leoncini S,Signorini C,Cortelazzo A,Rovero P,Durand T,Ciccoli L,Papini AM,Hayek J

    更新日期:2016-04-01 00:00:00

  • Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

    abstract::In the past decade significant advantages have been made in the treatment of rheumatoid arthritis (RA) and therapeutic strategies have changed a lot. These days, highly effective disease modifying anti-rheumatic drugs enable intervention early in the disease process, in order to prevent major joint damage. For years, ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.02.001

    authors: Vallbracht I,Helmke K

    更新日期:2005-07-01 00:00:00

  • The complex immunogenetic basis of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex tr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.01.001

    authors: Castro J,Balada E,Ordi-Ros J,Vilardell-Tarrés M

    更新日期:2008-05-01 00:00:00

  • COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

    abstract::The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term "hyperferritinemic syndromes" and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102573

    authors: Colafrancesco S,Alessandri C,Conti F,Priori R

    更新日期:2020-07-01 00:00:00

  • Intravenous immunoglobulin: exploiting the potential of natural antibodies.

    abstract::Antibodies present in healthy conditions in the absence of deliberate immunization or infections are called natural antibodies. A significant proportion of natural antibody pool is believed to interact with self-antigens, and thus is called natural autoantibodies. Natural autoantibodies belong to IgG, IgM and IgA subc...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.02.006

    authors: Kaveri SV

    更新日期:2012-09-01 00:00:00

  • Tools for critical appraisal of evidence in studies of diagnostic accuracy.

    abstract::Studies of accuracy are often more complex to understand than clinical trials, since there can be more than one outcome and scope (screening, diagnosis, and prognosis) and because results have to be reported in more than one way, than in clinical trials (relative risk or odds ratio). Sensitivity and specificity are co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2012.07.004

    authors: Giavarina D

    更新日期:2012-12-01 00:00:00

  • Improving the effectiveness of autoantibody testing in the clinic.

    abstract::To enable clinicians to use autoantibody tests sensibly and economically, laboratories providing the test service have a responsibility to supply the test 'specifications'. This should include information about the test's validity and reliability, its normal range or range within a control population, its sensitivity ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00061-7

    authors: Sturgess A,Edmonds J

    更新日期:2002-10-01 00:00:00

  • The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials.

    abstract::The impact of dietary interventions such as specific types of diet or nutritional supplements in rheumatoid arthritis (RA) has been subject to increased attention in recent years. The recognition of the unmet need to better understand the effects of specific dietary interventions on disease outcomes in RA, along with ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.007

    authors: Petersson S,Philippou E,Rodomar C,Nikiphorou E

    更新日期:2018-11-01 00:00:00

  • Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).

    abstract::Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.03.019

    authors: Sun Y,Zhang W,Evans JF,Floreani A,Zou Z,Nishio Y,Qi R,Leung PS,Bowlus CL,Gershwin ME

    更新日期:2016-08-01 00:00:00

  • Novel risk factors related to cancer in scleroderma.

    abstract:OBJECTIVE:Emerging data have shown an increased risk of malignancy among patients diagnosed with systemic sclerosis (SSc) so identification of risk factors linking both disorders might have prognostic implications. The aim of this study was to assess the clinical and treatment-related risk factors for cancer in a singl...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.03.012

    authors: Bernal-Bello D,de Tena JG,Guillén-Del Castillo A,Selva-O'Callaghan A,Callejas-Moraga EL,Marín-Sánchez AM,Fonollosa-Pla V,Simeón-Aznar CP

    更新日期:2017-05-01 00:00:00

  • Treatment of Raynaud's phenomenon.

    abstract::Raynaud's phenomenon is an episodic vasospasm of the peripheral arteries, causing pallor followed by cyanosis and redness with pain and sometimes paraesthesia, and, rarely, ulceration of the fingers and toes. Primary or idiopathic Raynaud's phenomenon (Raynaud's disease) occurs without an underlying disease. Secondary...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.002

    authors: García-Carrasco M,Jiménez-Hernández M,Escárcega RO,Mendoza-Pinto C,Pardo-Santos R,Levy R,Maldonado CG,Chávez GP,Cervera R

    更新日期:2008-10-01 00:00:00

  • Regulation of Fli1 gene expression and lupus.

    abstract::Ets transcription factors function throughout development in such varied processes as cellular proliferation, apoptosis, differentiation and migration. Many have been implicated to play important roles in hematopoiesis, vasculogenesis/angiogenesis and myogenesis. Fli1 is an Ets family member that is essential for deve...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.10.005

    authors: Nowling TK,Gilkeson GS

    更新日期:2006-07-01 00:00:00

  • New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.

    abstract::Antimalarials have been an effective and safe treatment for autoimmune rheumatic diseases such as systemic lupus erythematosus for more than a hundred years. There are surprisingly few reports of hydroxychloroquine use in the systemic vasculitides. Hydroxychloroquine has antithrombotic, cardiovascular, antimicrobial a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.01.016

    authors: Casian A,Sangle SR,D'Cruz DP

    更新日期:2018-07-01 00:00:00

  • Impaired clearance of dying cells in systemic lupus erythematosus.

    abstract::Impaired clearance of apoptotic cell material has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Besides many other molecules, C1q and DNaseI contribute to an efficient clearance of dying cells. A frequently observed factor in SLE patients is the accumulation of unusually large amounts of a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.10.007

    authors: Gaipl US,Voll RE,Sheriff A,Franz S,Kalden JR,Herrmann M

    更新日期:2005-04-01 00:00:00

  • Prednisone in lupus nephritis: how much is enough?

    abstract:OBJECTIVE:To assess the effectiveness and safety of a protocol using medium doses of prednisone to treat lupus nephritis. METHODS:Patients receiving the 'Cruces-protocol cohort' (CPC) were paired 1:2 with patients from the 'historic cohort' (HC). The CPC received medium doses of prednisone combined with methyl-prednis...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2013.10.013

    authors: Ruiz-Irastorza G,Danza A,Perales I,Villar I,Garcia M,Delgado S,Khamashta M

    更新日期:2014-02-01 00:00:00